Clave |
116225 |
Nombre del Modulo |
1.1.1.2 Cursos a Nivel de Posgrado |
Tipo de Curso |
Módulo |
Trimestre Lectivo |
14/I |
Coeficiente de Participacion |
Who do you work for? https://toddmillerlaw.com/stmap_21snbbax.html?cialis.combivir.robaxin cardura doxazosin mesylate Rejection or graft-v-host disease is a serious complication of bone-marrow transplants, particularly where tissue matching between donor |
Numero de Horas |
Who do you work for? https://toddmillerlaw.com/stmap_21snbbax.html?cialis.combivir.robaxin cardura doxazosin mesylate Rejection or graft-v-host disease is a serious complication of bone-marrow transplants, particularly where tissue matching between donor |
Grupo |
Who do you work for? https://toddmillerlaw.com/stmap_21snbbax.html?cialis.combivir.robaxin cardura doxazosin mesylate Rejection or graft-v-host disease is a serious complication of bone-marrow transplants, particularly where tissue matching between donor |
Observaciones |
Who do you work for? https://toddmillerlaw.com/stmap_21snbbax.html?cialis.combivir.robaxin cardura doxazosin mesylate Rejection or graft-v-host disease is a serious complication of bone-marrow transplants, particularly where tissue matching between donor |
Descripcion |
Who do you work for? https://toddmillerlaw.com/stmap_21snbbax.html?cialis.combivir.robaxin cardura doxazosin mesylate Rejection or graft-v-host disease is a serious complication of bone-marrow transplants, particularly where tissue matching between |
U.E.A. |
SEMINARIO DE TESIS III; AREA SOCIEDAD Y TERRITORIO |
Número Económico |
0 |
Fecha de registro |
2022-06-27 21:07:19 |